These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
236 related articles for article (PubMed ID: 19342686)
1. p53 Attenuates lipopolysaccharide-induced NF-kappaB activation and acute lung injury. Liu G; Park YJ; Tsuruta Y; Lorne E; Abraham E J Immunol; 2009 Apr; 182(8):5063-71. PubMed ID: 19342686 [TBL] [Abstract][Full Text] [Related]
2. Daidzein attenuates lipopolysaccharide-induced acute lung injury via toll-like receptor 4/NF-kappaB pathway. Feng G; Sun B; Li TZ Int Immunopharmacol; 2015 Jun; 26(2):392-400. PubMed ID: 25887269 [TBL] [Abstract][Full Text] [Related]
3. p38 Mitogen-activated protein kinase up-regulates LPS-induced NF-kappaB activation in the development of lung injury and RAW 264.7 macrophages. Kim HJ; Lee HS; Chong YH; Kang JL Toxicology; 2006 Aug; 225(1):36-47. PubMed ID: 16793190 [TBL] [Abstract][Full Text] [Related]
4. Ulinastatin Protects Against LPS-Induced Acute Lung Injury By Attenuating TLR4/NF-κB Pathway Activation and Reducing Inflammatory Mediators. Cao C; Yin C; Shou S; Wang J; Yu L; Li X; Chai Y Shock; 2018 Nov; 50(5):595-605. PubMed ID: 29324628 [TBL] [Abstract][Full Text] [Related]
5. The effect of magnolol on the Toll-like receptor 4/nuclear factor κB signaling pathway in lipopolysaccharide-induced acute lung injury in mice. Yunhe F; Bo L; Xiaosheng F; Fengyang L; Dejie L; Zhicheng L; Depeng L; Yongguo C; Xichen Z; Naisheng Z; Zhengtao Y Eur J Pharmacol; 2012 Aug; 689(1-3):255-61. PubMed ID: 22683864 [TBL] [Abstract][Full Text] [Related]
6. Knockdown of versican V1 induces a severe inflammatory response in LPS-induced acute lung injury via the TLR2-NF-κB signaling pathway in C57BL/6J mice. Xu L; Xue T; Zhang J; Qu J Mol Med Rep; 2016 Jun; 13(6):5005-12. PubMed ID: 27109786 [TBL] [Abstract][Full Text] [Related]
7. Inhibitory effect of chroman carboxamide on interleukin-6 expression in response to lipopolysaccharide by preventing nuclear factor-kappaB activation in macrophages. Kim BH; Lee KH; Chung EY; Chang YS; Lee H; Lee CK; Min KR; Kim Y Eur J Pharmacol; 2006 Aug; 543(1-3):158-65. PubMed ID: 16797005 [TBL] [Abstract][Full Text] [Related]
8. Lipopolysaccharide downregulates the expression of p53 through activation of MDM2 and enhances activation of nuclear factor-kappa B. Odkhuu E; Mendjargal A; Koide N; Naiki Y; Komatsu T; Yokochi T Immunobiology; 2015 Jan; 220(1):136-41. PubMed ID: 25172547 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of mammalian target of rapamycin augments lipopolysaccharide-induced lung injury and apoptosis. Fielhaber JA; Carroll SF; Dydensborg AB; Shourian M; Triantafillopoulos A; Harel S; Hussain SN; Bouchard M; Qureshi ST; Kristof AS J Immunol; 2012 May; 188(9):4535-42. PubMed ID: 22450807 [TBL] [Abstract][Full Text] [Related]
10. Kaempferol regulates MAPKs and NF-κB signaling pathways to attenuate LPS-induced acute lung injury in mice. Chen X; Yang X; Liu T; Guan M; Feng X; Dong W; Chu X; Liu J; Tian X; Ci X; Li H; Wei J; Deng Y; Deng X; Chi G; Sun Z Int Immunopharmacol; 2012 Oct; 14(2):209-16. PubMed ID: 22835426 [TBL] [Abstract][Full Text] [Related]
11. Baicalin exerts protective effects against lipopolysaccharide-induced acute lung injury by regulating the crosstalk between the CX3CL1-CX3CR1 axis and NF-κB pathway in CX3CL1-knockout mice. Ding XM; Pan L; Wang Y; Xu QZ Int J Mol Med; 2016 Mar; 37(3):703-15. PubMed ID: 26782291 [TBL] [Abstract][Full Text] [Related]
12. Hyaluronan ameliorates LPS-induced acute lung injury in mice via Toll-like receptor (TLR) 4-dependent signaling pathways. Xu C; Chen G; Yang W; Xu Y; Xu Y; Huang X; Liu J; Feng Y; Xu Y; Liu B Int Immunopharmacol; 2015 Oct; 28(2):1050-8. PubMed ID: 26321117 [TBL] [Abstract][Full Text] [Related]
13. Diosmin downregulates the expression of T cell receptors, pro-inflammatory cytokines and NF-κB activation against LPS-induced acute lung injury in mice. Imam F; Al-Harbi NO; Al-Harbi MM; Ansari MA; Zoheir KM; Iqbal M; Anwer MK; Al Hoshani AR; Attia SM; Ahmad SF Pharmacol Res; 2015 Dec; 102():1-11. PubMed ID: 26361726 [TBL] [Abstract][Full Text] [Related]
14. Lipopolysaccharide prevents valproic acid-induced apoptosis via activation of nuclear factor-κB and inhibition of p53 activation. Tsolmongyn B; Koide N; Odkhuu E; Haque A; Naiki Y; Komatsu T; Yoshida T; Yokochi T Cell Immunol; 2013 Apr; 282(2):100-5. PubMed ID: 23770718 [TBL] [Abstract][Full Text] [Related]
15. Asiaticoside attenuates lipopolysaccharide-induced acute lung injury via down-regulation of NF-κB signaling pathway. Qiu J; Yu L; Zhang X; Wu Q; Wang D; Wang X; Xia C; Feng H Int Immunopharmacol; 2015 May; 26(1):181-7. PubMed ID: 25835778 [TBL] [Abstract][Full Text] [Related]
16. Protective effect of catalpol on lipopolysaccharide-induced acute lung injury in mice. Fu K; Piao T; Wang M; Zhang J; Jiang J; Wang X; Liu H Int Immunopharmacol; 2014 Dec; 23(2):400-6. PubMed ID: 25063711 [TBL] [Abstract][Full Text] [Related]
17. Echinocystic acid ameliorates lung inflammation in mice and alveolar macrophages by inhibiting the binding of LPS to TLR4 in NF-κB and MAPK pathways. Joh EH; Gu W; Kim DH Biochem Pharmacol; 2012 Aug; 84(3):331-40. PubMed ID: 22564908 [TBL] [Abstract][Full Text] [Related]
18. C1P Attenuates Lipopolysaccharide-Induced Acute Lung Injury by Preventing NF-κB Activation in Neutrophils. Baudiß K; de Paula Vieira R; Cicko S; Ayata K; Hossfeld M; Ehrat N; Gómez-Muñoz A; Eltzschig HK; Idzko M J Immunol; 2016 Mar; 196(5):2319-26. PubMed ID: 26800872 [TBL] [Abstract][Full Text] [Related]
19. Schisantherin A protects lipopolysaccharide-induced acute respiratory distress syndrome in mice through inhibiting NF-κB and MAPKs signaling pathways. Zhou E; Li Y; Wei Z; Fu Y; Lei H; Zhang N; Yang Z; Xie G Int Immunopharmacol; 2014 Sep; 22(1):133-40. PubMed ID: 24975658 [TBL] [Abstract][Full Text] [Related]
20. Diarctigenin, a lignan constituent from Arctium lappa, down-regulated zymosan-induced transcription of inflammatory genes through suppression of DNA binding ability of nuclear factor-kappaB in macrophages. Kim BH; Hong SS; Kwon SW; Lee HY; Sung H; Lee IJ; Hwang BY; Song S; Lee CK; Chung D; Ahn B; Nam SY; Han SB; Kim Y J Pharmacol Exp Ther; 2008 Nov; 327(2):393-401. PubMed ID: 18694995 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]